Date

Title

View

03 Dec 15

SYGNIS AG concludes agreement with Lucigen Corp. as a distributor for their NGS portfolio focused on the clinical oncology research market in the U.S.

View View

02 Dec 15

SYGNIS AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

02 Dec 15

SYGNIS AG signs distribution agreement with Mayflower Bioscience for the US market

View View

18 Nov 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

18 Nov 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

18 Nov 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

17 Nov 15

SYGNIS AG plans to issue new shares to finance further growth and commercialization of proprietary product portfolio

View View

17 Nov 15

SYGNIS AG plans to issue new shares to finance further growth and commercialization of proprietary product portfolio

View View

06 Nov 15

SYGNIS reports nine month results for the period ended September 30, 2015

View View

27 Oct 15

SYGNIS AG to present at BIO-Europe 2015 International Partnering Conference

View View

14 Oct 15

SYGNIS AG to host live webinar on its revolutionary SunScript(TM) RT technology for reliable and robust RNA amplification

View View

01 Oct 15

SYGNIS AG: SYGNIS to present its innovative TruePrime(TM) and SunScript(TM) technologies for DNA amplification and sequencing at the American Society of Human Genetics Annual Meeting, ASHG 2015 in Baltimore

View View